Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer [Yahoo! Finance]
Edesa Biotech, Inc. - Common Shares (EDSA)
Company Research
Source: Yahoo! Finance
He brings more than 20 years of senior executive experience in the life science industry across business development, operations, and strategy STRASBOURG, France & MONTREAL & BOSTON, April 17, 2024 BUSINESS WIRE )--Domain Therapeutics a global clinical-stage biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the appointment of Sean A. MacDonald as its Chief Executive Officer (CEO). Sean, formerly Executive Strategic Advisor and most recently Chief Business Officer of Domain Therapeutics, has played a pivotal role over the past year in defining, alongside Domain's management team, both corporate and clinical strategy. His efforts have been instrumental in positioning the development stage assets of Domain's proprietary portfolio of GPCR-targeting immunotherapies. Sean's in-depth knowledge and experience within all aspects of Domain's operations, will be invaluable in driving the Company'
Show less
Read more
Impact Snapshot
Event Time:
EDSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDSA alerts
High impacting Edesa Biotech, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
EDSA
News
- BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS [Yahoo! Finance]Yahoo! Finance
- BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDSAccesswire
- Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- Edesa Biotech Reports Fiscal 2nd Quarter 2024 ResultsAccesswire
- Edesa Biotech to Participate in Bloom Burton Healthcare Investor ConferenceAccesswire
EDSA
Sec Filings
- 6/24/24 - Form 8-K
- 6/4/24 - Form 4
- 6/3/24 - Form SC
- EDSA's page on the SEC website